RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies.
Martucciello S, Lavric M, Toth B, Korponay-Szabo I, Nadalutti C, Myrsky E, Rauhavirta T, Esposito C, Sulic AM, Sblattero D, Marzari R, Mäki M, Kaukinen K, Lindfors K, Caja S.
Martucciello S, et al. Among authors: esposito c.
J Mol Med (Berl). 2012 Jul;90(7):817-26. doi: 10.1007/s00109-011-0853-0. Epub 2012 Jan 6.
J Mol Med (Berl). 2012.
PMID: 22223195